Evaxion Biotech AS (EVAX)
3.78
+0.06
(+1.61%)
USD |
NASDAQ |
May 15, 14:48
Evaxion Biotech Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -5.19M |
| March 31, 2022 | -8.186M |
| December 31, 2021 | -4.115M |
| September 30, 2021 | -6.295M |
| June 30, 2021 | -7.488M |
| Date | Value |
|---|---|
| March 31, 2021 | -4.035M |
| December 31, 2020 | -4.42M |
| September 30, 2020 | -2.765M |
| June 30, 2020 | -2.303M |
| March 31, 2020 | -2.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.186M
Minimum
Mar 2022
-2.303M
Maximum
Jun 2020
-4.775M
Average
-4.268M
Median
Cash from Operations (Quarterly) Benchmarks
| DBV Technologies SA | -34.69M |
| Ascendis Pharma A/S | -110.34M |
| Cellectis SA | 39.72M |
| Adaptimmune Therapeutics PLC | -14.68M |
| Akari Therapeutics PLC | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -237.1% |